Featured News
Over the past few months, we have asked the ADHD community to support us in changing the way ADHD medications are made availability under the Pharmaceutical Benefits Scheme (PBS). ADHD Australia would like to thank all those who wrote supporting statements, both last year and earlier this year, to the Pharmaceutical Benefits Advisory Committee (PBAC).…
Read More
Deakin University and the Centre for Social & Early Emotional Development (SEED) is undertaking research into Understanding the impact of COVID-19 on the wellbeing of families affected by ADHD. Associate Professor Emma Sciberas, Higher Degree Coordinator, School of Psychology, and Co-leader Intervention Sciences, Centre for Social & Early Emotional Development, Deakin University in Melbourne, is…
Read More
Monash University – The Alfi Virtual Reality Project – is undertaking research into the teenager attention difficulties. An easy to complete online survey and an interesting time of participation that promises to offer some great insights into teenager attention difficulties. The Alfi Virtual Reality team at Monash University’s Turner Clinic for Brain and Mental Health…
Read More
Shire (a Takeda company), the manufacturer of INTUNIV, has recently experienced a supply interruption which has resulted in a shortage of INTUNIV 2mg in Australia. To ensure ongoing access to INTUNIV, Shire has made available INTUNIV 2mg sample packs which are normally provided to doctors as starter packs. This is expected to cover patient needs…
Read More
ADHD Australia has been monitoring the official Australian Government Health Advice about Covid-19 and has been in contact with the various Support Groups across the country. All of the Support Groups meetings and events are now not able to go ahead, which is in line with the Government Health Advice. Until the official health advice…
Read More
Monash University – School of Psychological Sciences, is undertaking research into the Diagnosis and Management of Children with Autism and ADHD (DAMCAA) Study. An easy to complete survey that promises to offer some great insights into barriers/ challenges faced by families. The DAMCAA study is looking for families across Australia who have a child aged…
Read More
Shire (a Takeda company), is the manufacturer of VYVANSE and INTUNIV which unfortunately had experienced some interruption of the supply of both medications over the Christmas holiday period. ADHD Australia has been in contact with Shire, who manufactures INTUNIV 1mg and VYVANSE 70mg, and I am pleased to advise that both products have now returned…
Read More
Shire (a Takeda company), is the manufacturer of VYVANSE who have unfortunately experienced an interruption to their manufacturing for the VYVANSE 70mg. This has resulted in a shortage within Australia of this 70mg dosage strength only. They expect the supply of the VYVANSE 70mg will return to normal in February 2020. ADHD Australia has been…
Read More
ADHD Australia officially launched its new website on Thursday 5th December at a function hosted by the Westmead Hospital Foundation. At the event were representatives from each of the organisations involved in the collaborative approach made to the funder of the project, IMB Bank Community Foundation. IMB was represented by Ms Rachael Core who is…
Read More
Catherine Cook had a sudden moment of clarity the day her 10-year-old son was diagnosed with attention deficit hyperactivity disorder (ADHD). “They told me it was hereditary and I thought, ‘Uh-oh, that’s me,’ the Sydney mother-of-two said. Ms Cook, 34, has a vague memory of being told she had attention deficit disorder when she was…
Read More